2 Obesity Treatment Stocks Morgan Stanley Likes More than Novo Nordisk
While Novo Nordisk's Wegovy currently dominates the obesity treatment market, Morgan Stanley sees more upside potential for LLY and AZN stocks going forward.
Barchart ·